Dr. Dana P. Albon, MD

Dr. Albon practices at UVA University Medical Center in Charlottesville, Virginia.

Dr. Albon's NPI, 1932322948, was assigned on April 10, 2007. Dr. Albon graduated from Iuliu Hatieganu University of Medicine and Pharmacy in 2001. Dr. Albon holds Virginia license 0101255996.

Dr. Albon's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 760-3439.

Dr. Albon's primary practice is UVA University Medical Center in Charlottesville, Virginia. Dr. Albon is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Albon to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Albon practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Albon's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Albon is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Albon's licenses on file in 2 states: Virginia and North Carolina.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD) and pneumonia among the conditions Dr. Albon treats.

CMS data shows 1,052 Medicare services from Dr. Albon across 11 procedure codes in 2024, for 395 Medicare patients. Medicare paid $40,926 for them.

CMS counts 395 Medicare patients who saw Dr. Albon in 2024. The largest group is 65 to 74, with 166 patients. 74% of them have high cholesterol, and 70% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Albon's median patient age at 60, with 61% women.

In 2024, Dr. Albon wrote 1,786 Medicare Part D claims for 104 patients. CMS names the drug for 1,504 of them, across 34 drugs with 11 or more claims each, at $8,847,892 in total drug cost. In 2023, CMS named 1,257 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Albon for performance year 2024, reported as part of a group. Dr. Albon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Albon as offering telehealth.

Dmand AI links 34 papers to Dr. Albon, published from 2017 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Cystic Fibrosis, COVID-19 and Telemedicine. Dr. Albon has published most often in Pediatr Pulmonol. Dr. Albon's most frequent co-authors are Lindsay A. Somerville, MD, Thida Ong, MD and Thida Ong, MD.

Dmand AI links Dr. Albon to 1 clinical trial. Conditions studied include Cystic Fibrosis and Infant, Newborn, Diseases.

CMS Open Payments shows 16 general payments to Dr. Albon from 3 drug and device companies from 2017 to 2023. Consulting fees make up the largest share, 75% of the total. Vertex Pharmaceuticals Incorporated paid the most, $5,728.

Dmand AI lists 1 award for Dr. Albon, most recently CMS Stage 1 EHR in 2013.

Dr. Albon graduated from Iuliu Hatieganu University of Medicine and Pharmacy in 2001.

Dr. Albon is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.